Literature DB >> 35560183

Differentiation of circulating monocytes into macrophages with metabolically activated phenotype regulates inflammation in dyslipidemia patients.

Elena Berenice Martínez-Shio1, Ángel Martín Cárdenas-Hernández1, Verónica Jiménez-Suárez1, Laura Sherell Marín-Jáuregui1, Claudia Castillo-Martin Del Campo2, Roberto González-Amaro1, Carlos D Escobedo-Uribe3, Adriana Elizabeth Monsiváis-Urenda1.   

Abstract

Macrophages are mediators of inflammation having an important role in the pathogenesis of cardiovascular diseases. Recently, a pro-inflammatory subpopulation, known as metabolically activated macrophages (MMe), has been described in conditions of obesity and metabolic syndrome where they are known to release cytokines that can promote insulin resistance. Dyslipidemia represents an important feature in metabolic syndrome and corresponds to one of the main modifiable risk factors for the development of cardiovascular diseases. Circulating monocytes can differentiate into macrophages under certain conditions. They correspond to a heterogeneous population, which include inflammatory and anti-inflammatory subsets; however, there is a wide spectrum of phenotypes. Therefore, we decided to investigate whether the metabolic activated monocyte (MoMe) subpopulation is already present under dyslipidemia conditions. Secondly, we assessed whether different levels of cholesterol and triglycerides play a role in the polarization towards the metabolic phenotype (MMe) of macrophages. Our results indicate that MoMe cells are found in both healthy and dyslipidemia patients, with cells displaying the following metabolic phenotype: CD14varCD36+ABCA1+PLIN2+. Furthermore, the percentages of CD14++CD68+CD80+ pro-inflammatory monocytes are higher in dyslipidemia than in healthy subjects. When analysing macrophage differentiation, we observed that MMe percentages were higher in the dyslipidemia group than in healthy subjects. These MMe have the ability to produce high levels of IL-6 and the anti-inflammatory cytokine IL-10. Furthermore, ABCA1 expression in MMe correlates with LDL serum levels. Our study highlights the dynamic contributions of metabolically activated macrophages in dyslipidemia, which may have a complex participation in low-grade inflammation due to their pro- and anti-inflammatory function.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Metabolically activated macrophages; dyslipidemia; immune regulation; interleukin-10 (IL-10); monocytes

Mesh:

Substances:

Year:  2022        PMID: 35560183      PMCID: PMC9113394          DOI: 10.1093/cei/uxac013

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization.

Authors:  Carey N Lumeng; Jennifer L Bodzin; Alan R Saltiel
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Enucleation of primitive erythroid cells generates a transient population of "pyrenocytes" in the mammalian fetus.

Authors:  Kathleen E McGrath; Paul D Kingsley; Anne D Koniski; Rebecca L Porter; Timothy P Bushnell; James Palis
Journal:  Blood       Date:  2007-11-21       Impact factor: 22.113

3.  Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages.

Authors:  W K Eddie Ip; Namiko Hoshi; Dror S Shouval; Scott Snapper; Ruslan Medzhitov
Journal:  Science       Date:  2017-05-05       Impact factor: 47.728

4.  Metabolic Induction of Trained Immunity through the Mevalonate Pathway.

Authors:  Siroon Bekkering; Rob J W Arts; Boris Novakovic; Ioannis Kourtzelis; Charlotte D C C van der Heijden; Yang Li; Calin D Popa; Rob Ter Horst; Julia van Tuijl; Romana T Netea-Maier; Frank L van de Veerdonk; Triantafyllos Chavakis; Leo A B Joosten; Jos W M van der Meer; Henk Stunnenberg; Niels P Riksen; Mihai G Netea
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

5.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages.

Authors:  Mario Kratz; Brittney R Coats; Katherine B Hisert; Derek Hagman; Vesco Mutskov; Eduard Peris; Kelly Q Schoenfelt; Jessica N Kuzma; Ilona Larson; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David Gozal; Seungmin Hwang; Pradeep K Singh; Lev Becker
Journal:  Cell Metab       Date:  2014-09-18       Impact factor: 27.287

6.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.

Authors:  Shinya U Amano; Jessica L Cohen; Pranitha Vangala; Michaela Tencerova; Sarah M Nicoloro; Joseph C Yawe; Yuefei Shen; Michael P Czech; Myriam Aouadi
Journal:  Cell Metab       Date:  2013-12-26       Impact factor: 27.287

7.  Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages.

Authors:  M A Valtierra-Alvarado; J E Castañeda Delgado; S I Ramírez-Talavera; G Lugo-Villarino; F Dueñas-Arteaga; A Lugo-Sánchez; M S Adame-Villalpando; B Rivas-Santiago; J Enciso-Moreno; C J Serrano
Journal:  J Diabetes Complications       Date:  2020-08-13       Impact factor: 2.852

8.  Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.

Authors:  Anette Christ; Patrick Günther; Mario A R Lauterbach; Peter Duewell; Debjani Biswas; Karin Pelka; Claus J Scholz; Marije Oosting; Kristian Haendler; Kevin Baßler; Kathrin Klee; Jonas Schulte-Schrepping; Thomas Ulas; Simone J C F M Moorlag; Vinod Kumar; Min Hi Park; Leo A B Joosten; Laszlo A Groh; Niels P Riksen; Terje Espevik; Andreas Schlitzer; Yang Li; Michael L Fitzgerald; Mihai G Netea; Joachim L Schultze; Eicke Latz
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

9.  A first-generation microsatellite-based genetic linkage map of the Siberian jay (Perisoreus infaustus): insights into avian genome evolution.

Authors:  Sonja Jaari; Meng-Hua Li; Juha Merilä
Journal:  BMC Genomics       Date:  2009-01-03       Impact factor: 3.969

10.  Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012.

Authors:  César Hernández-Alcaraz; Carlos A Aguilar-Salinas; Kenny Mendoza-Herrera; Andrea Pedroza-Tobías; Salvador Villalpando; Teresa Shamah-Levy; Juan Rivera-Dommarco; Mauricio Hernández-Ávila; Simón Barquera
Journal:  Salud Publica Mex       Date:  2020 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.